DBV Technologies Reports Full Year 2022 Financial Results and Business Update
Montrouge, France, March 2, 2023
DBV Technologies Reports Full Year 2022 Financial Results and Business Update
DBV Technologies (Euronext:DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported financial results for the full year 2022. The audit procedures have been substantially completed by the Company’s statutory auditors and financials – prepared under both US GAAP and IFRS for the purpose of Form 10-K and Universal Registration Document respectively – were approved by the Board of Directors on March 2, 2023.
Related news for (DBVT)
- Top Stocks in the News LXRX, SYTA, DBVT, WIMI, MLGO, and PRTG
- DBV Technologies Locks in $306M to Rocket Viaskin Peanut Patch to U.S. Shores
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/28/25 08:00 AM
- MoBot’s Stock Market Highlights – 03/28/25 07:00 AM
- Today’s Top Performers: MoBot’s Market Review 03/28/25 06:00 AM